This article is more than 5 years old. Information may no longer be current.

Biomet receives FDA clearance for Active Articulation E1 Dual Mobility Hip System

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Biomet, Inc., announced FDA clearance of its Active Articulation E1 Dual Mobility Hip System. According to a company press release, the Active Articulation Hip System is Biomet’s first hip system in the United States to merge the concept of dual mobility with the benefits of Biomet’s exclusive E1 Antioxidant Infused technology and a proven cup design.

“The Active Articulation Hip System provides an excellent combination of wear resistance and implant stability,” stated Jon Serbousek, president of Biomet’s U.S. orthopedics division, in the release. “We believe this new product will provide an important implant solution to orthopedic surgeons performing hip replacement surgery.”

The dual mobility hip concept utilizes a small femoral head that articulates within polyethylene, according to te release. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup.